Orthofix Medical

Orthofix Medical R&D per Employee

The R&D Spending per Employee of Orthofix Medical (OFIX) as of Oct 30, 2026 is 35,583.80 USD. In the previous year, R&D Spending per Employee was 45,883.49 USD — a change of -22.45% (lower).

R&D per Employee

35,583.80USD

YoY

-22.45%

Last updated:

R&D Spending per Employee of Orthofix Medical is 2025 35,583.80 USD. R&D Spending per Employee of Orthofix Medical was 2024 45,883.49 USD. It decreases by -22.45% lower compared to the previous year.

The Orthofix Medical R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
20,696.57 USD
Jan 1, 2019
21,580.69 USD
Jan 1, 2020
24,333.96 USD
Jan 1, 2021
30,916.51 USD
Jan 1, 2022
30,570.09 USD
Jan 1, 2023
49,988.16 USD
Jan 1, 2024
45,883.49 USD
Jan 1, 2025
35,583.80 USD
The Orthofix Medical R&D per Employee history
YEARR&D per EmployeeYoY
35,583.80USD-22.45%
45,883.49USD-8.21%
49,988.16USD+63.52%
30,570.09USD-1.12%
30,916.51USD+27.05%
24,333.96USD+12.76%
21,580.69USD+4.27%
20,696.57USD+11.85%
18,504.67USD+3.11%
17,945.79USD+9.15%
16,441.74USD+5.58%
15,572.59USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Orthofix Medical Stock analysis

What does Orthofix Medical do? Orthofix Medical Inc is a leading global company in the field of orthopedic medical devices. The company is headquartered in Lewisville, Texas, USA and has been publicly traded since 1987. Orthofix's history dates back to the 1970s when it was founded as a small startup company. Since then, it has grown into a multinational company employing several thousand employees worldwide. Orthofix's business model is based on developing, manufacturing, and distributing orthopedic products and services that contribute to the restoration of mobility and quality of life for people with orthopedic conditions and injuries. The company offers a wide range of products ranging from implantable medical devices to conservative therapy options. Orthofix operates in three main divisions: 1. Spinal Implants and Biologics: This includes products such as intervertebral disc implants, interactive spinal fracture systems, and biological products to support bone healing. 2. Extremity Fixation: In this area, the company offers various implants for stabilizing fractures and joints, such as wrist supports or nail implants for stabilizing bone fractures in the arms and legs. 3. Orthofix PhysioStim: Orthofix PhysioStim is a non-invasive therapy option that supports bone and soft tissue healing. It is a portable device that generates electrical impulses and is used over an extended period of time. Orthofix's broad product portfolio also includes specialized products and services tailored to specific medical needs and groups. For example, the company offers some products specifically for children, such as the Pediatric Locking Nail System, a nail system for treating forearm and leg fractures in children. The company also provides products for animals, such as the VetLok External Fixation System, an implant system for stabilizing bone fractures in animals. Orthofix is committed to quality and product innovation to meet the needs of its customers and differentiate itself in a highly competitive market. The company continuously invests in research and development to develop new technologies and products that contribute to improving patient outcomes and support the work of doctors and surgeons. Overall, Orthofix Medical Inc is a leading company in the field of orthopedic medical devices, offering a wide range of products and services to support patients in restoring their mobility and quality of life. The company is committed to quality, innovation, and customer satisfaction, and invests in research and development to play a leading role in a competitive market. Orthofix Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orthofix Medical stock

R&D Spending per Employee of Orthofix Medical is 35,583.80 USD in 2025.

R&D Spending per Employee of Orthofix Medical changed from 45,883.49 USD to 35,583.80 USD, representing a -22.45% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Orthofix Medical since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Orthofix Medical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Orthofix Medical

All Key Metrics — Orthofix Medical